WSJ Tech News Briefing · Tuesday, September 8, 2026
Medical technology firm Boston Scientific announced it will likely miss its financial guidance for the third quarter and full year due to a recent cyberattack that disrupted its operations, affecting manufacturing, processing, and order shipments. While the company is making progress in restoring affected systems and its distribution network, it stated the cyberattack is not expected to materially impact its long-term financial condition.
“And medical technology company Boston Scientific said it likely won't meet its financial guidance due to the cyberattack that has disrupted its operations.”
“Last month, the company reported unauthorized activity on some of its systems that have affected its ability to manufacture and process and ship customer orders.”
“But that it expects to miss its sales and adjusted per share earnings guidance for the third quarter and full year.”
“Still, the company said it does not expect the cyberattack will have a material impact on its long-term financial condition.”